Template ppt presentation

1
Viral Hepatitis Network
How to Collaborate with WHO for the Prevention
and Control of Viral Hepatitis
Dr. Hande Harmanci Global Hepatitis Programme
2

• In 2010, resolution WHA63.18 call for a
  comprehensive approach to the prevention and
  control of viral hepatitis.
• As a response, the Global Hepatitis Programme is
  established in December 2011 with a vision
• A world where viral hepatitis transmission is
  stopped and all have access to safe and effective
  care and treatment
• The complexity associated with different types of
  hepatitis viruses requires a tight partnership of
  all stakeholders

3
Ways of Collaboration

• Viral Hepatitis Network
• WHO Collaborating Centers

4
Viral Hepatitis Network(VHN)
5
Purpose

• To provide a forum for exchange of information
  and collaboration among the various stakeholders
  in order to implement a common viral hepatitis
  work plan

6
Objectives - I

• Raise awareness of the viral hepatitis problem
  globally.
• Foster partnerships among different groups
  relevant to regional and country goals.
• Generate country and regional data that
  contribute to a better understanding of viral
  hepatitis and related interventions.

7
Objectives - II

• Advocate for "research for policy" in viral
  hepatitis.
• Contribute to the prevention of transmission.
• Strengthen national and regional capacities for
  surveillance, prevention and control of viral
  hepatitis.
• Advocate for equity in access to treatment and
  medicines.

8
Members of the VHN
9
The Core Group

• A balanced representation of all WHO regions
• Develops the set of rules for the VHN
• Mandate
• Operational structure
• Membership
• First official meeting will be in the last
  quarter of 2012

10
Principles of Collaboration

• Share information voluntarily
• Enhance synergies by avoiding duplication of
  efforts
• Contribute to fill in knowledge gaps
• All members and collaborators will strive to
• Support the global hepatitis strategy
• Actively participate in VHN meetings and
  activities
• Actively strive to make the VHN effective and
  efficient

11
Establishing a Global WHO Network for Viral
Hepatitis
Meeting Report 16-17 October 2012 Izmir, Turkey
12
Steering Committee membersStructure
13
At this meeting of the Global HepNet, the
following technical working groups were formed
WHO Axis Global HepNet Technical Working Group Members
Raising awareness, promoting partnerships and mobilizing resources Advocacy and Communications Charles Gore
Evidence-based policy and data for action Surveillance Francisco Averhoff, Jorge E. Gonzalez, Belgin Ünal
Molecular Epi Hakan Abacioglu, David H. Muljono, Murat Sayan
Prevention of transmission Vaccination Selim Badur, Fuqiang Cui, Jorge E. Gonzalez, David H. Muljono
Screening, care and treatment Reference laboratories Hakan Abacioglu, Scott Bowden, Vladimir Chulanov, Jorge E. Gonzalez, Richard Tedder
Cross cutting Research Agenda Francisco Averhoff, Belgin Ünal
Hep E Rakesh Aggarwal, Jorge E. Gonzalez, Arzu Sayiner, Richard Tedder
Hep B David H. Muljono, Arzu Sayiner, Ponsiano Ocama
14
WHO Collaboration Centers
15
What are WHO collaborating centers?

• "an institution designated by the
  Director-General to form part of an international
  collaborative network carrying out activities in
  support of the Organization's programme at all
  levels.
• Today, over 800 collaborating
• centres in over 80 countries
• worldwide.
• http//www.who.int/collaboratingcentres/database/e
  n/

16
What do they do?

• The designation as a WHO CC formalizes a
  long-standing successful collaborative
  relationship between WHO and an external
  institution.
• The designation is implemented through a
  time-limited, contractual agreement of
  collaboration under which the designated
  institution commits to developing and
  implementing a series of collaborative activities
  with WHO.

17
Viral Hepatitis related CCs

• US-CDC, Division of Viral Hepatitis
• WHO CC for Reference and Research on Viral
  Hepatitis
• University of Western Cape (SA)
• WHO CC for Oral Health
• St.Vincent's Institute of Medical Research
• WHO CC for Diagnostics and Laboratory Support for
  HIV/AIDS and Other Blood-borne Infections
• HPA-UK
• WHO CC for Laboratory and Diagnostics Support

18
8 Key criteria

1. High scientific and technical standing nationally
   and internationally
2. Prominent place in the country's health,
   scientific or educational structures
3. High quality of leadership with sufficient number
   of qualified staff
4. Stability in terms of personnel, activity and
   funding
5. Strong working relationship with other
   institutions at national, regional and global
   level
6. Clear ability, capacity and readiness to
   contribute to WHO programme activities
7. Technical and geographical relevance of the
   institution and its activities to WHO's programme
   priorities
8. At least two (but in most cases many more) years
   of previous collaboration with WHO in carrying
   out jointly planned activities

19
Incentives for CC

• Enhanced visibility and recognition by national
  authorities
• Public attention to the health issues they work
  on
• Improved (international) opportunities to
  exchange information and develop technical
  cooperation with others
• Additional and sometimes important resources
  from funding partners

20
Conclusion

• VH is a huge burden on lives and economies of
  people
• Collaboration of different parties are needed to
  prevent and control VH.
• As a non-commercial, informal and voluntary
  collaboration, the VHN seeks to bring together
  representatives from the various sectors!

21

• hepatitis_at_who.int
• Thank you